Tracked deals
6
6 tracked deals across 2020-2026.
Washington, District of Columbia, United States
Danaher is a leading global life sciences and diagnostics innovator, accelerating the power of science and technology to improve human health. Danaher partners with customers worldwide across Life Sciences, Diagnostics, Biotechnology and related areas to architect solutions that bring science to life, spanning instruments, consumables, software, and services.
Tracked deals
6
6 tracked deals across 2020-2026.
Recent pace
2
2 tracked deals announced in the last 12 months.
Deal mix
Buyout
6 buyout
Last 4 years
Supporting Data
Leica Biosystems, a Danaher company, completed its acquisition of StatLab Medical Products, a provider of pre-analytical consumables and equipment for pathology labs. The deal expands Leica’s end-to-end anatomic and digital pathology ecosystem, supporting workflows from specimen preparation through staining, digital imaging and AI-enabled diagnosis.
Danaher has completed its acquisition of Masimo Corporation, a specialty diagnostics provider focused on pulse oximetry and patient monitoring solutions primarily used in acute care settings. Masimo will become a wholly-owned subsidiary of Danaher and continue operating under the Masimo brand as a stand-alone operating company within Danaher’s Diagnostics segment.
Danaher Corporation has acquired Genedata AG, a Basel-based provider of software solutions for biopharmaceutical R&D, and will integrate the company into its Life Sciences segment. The acquisition expands Danaher’s R&D workflow capabilities by adding Genedata’s data-driven informatics and automation tools to accelerate drug discovery and development.
Danaher Corporation entered into a definitive agreement to acquire Aldevron from EQT Private Equity for an enterprise value of approximately USD 9.6 billion. Aldevron, headquartered in Fargo, North Dakota with ~600 employees and additional operations in Madison, Wisconsin, will operate as a standalone company within Danaher's Life Sciences segment to expand Danaher's capabilities in genomic medicine and biologics manufacturing.
Danaher Corporation has acquired Vancouver-based Precision NanoSystems (PNI), a developer of lipid nanoparticle delivery technologies and microfluidic manufacturing platforms for genetic medicines. PNI will join Danaher's Life Sciences platform to expand its capabilities in mRNA and genetic-medicine development and complement existing portfolio companies such as Cytiva and Pall.
Danaher’s Water Quality platform has acquired Aquatic Informatics Inc. from XPV Water Partners. Aquatic Informatics is a water-focused software provider (serving more than 1,000 customers globally) whose data management and analytics capabilities will be integrated with Danaher’s Hach Claros offering to expand the platform’s hardware, software and services capabilities for municipal, environmental and industrial customers.
Turn tracked acquisition activity into an outreach-ready buyer list.